P. Giovinazzo

The BNP assay does not identify mild left ventricular diastolic dysfunction in asymptomatic diabetic patients.

R. Valle, E. Bagolin, C. Canali, P. Giovinazzo +4 more

2006European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology55 citations Open access

Semantic Scholar

P. Giovinazzo

Most-cited papers

B-type natriuretic Peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure.

B-type natriuretic peptide can predict the medium-term risk in patients with acute heart failure and preserved systolic function.

The BNP assay does not identify mild left ventricular diastolic dysfunction in asymptomatic diabetic patients.

White-coat hypertension: a selection bias? Harvest Study Investigators. Hypertension and Ambulatory Recording Venetia Study.

Relation of 24-hour ambulatory blood pressure and short-term blood pressure variability to seasonal changes in environmental temperature in stage I hypertensive subjects. Results of the Harvest Trial.

Prognostic value of plasma brain natriuretic peptide, urea nitrogen, and creatinine in outpatients >70 years of age with heart failure.

Fall in readmission rate for heart failure after implementation of B-type natriuretic peptide testing for discharge decision: a retrospective study.

The NT‐proBNP assay identifies very elderly nursing home residents suffering from pre‐clinical heart failure

White‐coat hypertension: a selection bias?

How often we need to measure brain natriuretic peptide (BNP) blood levels in patients admitted to the hospital for acute severe heart failure? Role of serial measurements to improve short-term prognostic stratification.

Early diagnosis of congestive heart failure: clinical utility of B-type natriuretic peptide testing associated with Doppler echocardiography

Plasma brain natriuretic peptide predicts short-term clinical outcome in heart failure patients with restrictive filling pattern.

B-type natriuretic peptide predicts postdischarge prognosis in elderly patients admitted due to cardiogenic pulmonary edema.

Prognostic role of B‐type natriuretic peptide in patients with diabetes and acute decompensated heart failure

Rapid brain natriuretic peptide test and Doppler echocardiography for early diagnosis of mild heart failure.

Target organ damage and ambulatory blood pressure in stage I hypertension. The Hypertension and Ambulatory Recording Venetia Study.

[BNP-guided therapy optimizes the timing of discharge and the medium term risk stratification in patients admitted for congestive heart failure].

35 B-type natriuretic peptide can predict the medium-term risk in patients with acute heart failure: the BIC study

217 Low readmission rate of low B-type natriuretic peptide patients admitted for heart failure are not further reduced by an active cardiological follow-up

637 Randomized comparison of the effects of treatment guided by plasma B‐type natriuretic peptide (BNP) concentrations versus empirical therapy in hospitalized patients

[Is early discharge possible in patients with uncomplicated heart failure? Cost-efficacy analysis].

A50Prevention of cardiotoxicity in adjuvant breast cancer (BC) therapy

55 Post‐discharge home surveillance of BNP levels allows early identification of decompensation and reduces readmission

RUOLO PROGNOSTICO DEL MONITORAGGIO AMBULATORIALE DELLA PRESSIONE ARTERIOSA DOPO UN INFARTO MIOCARDICO ACUTO

492 BNP and bioelectrical impedance analysis‐guided treatment for predicting outcome in patients hospitalised with acute heart failure

253 Reduced readmission rate for heart failure after implementation of B‐type natriuretic peptide testing for discharge decision

592 BNP and cardiac troponin T combination predicts cardiac events in patients hospitalized for acute heart failure

400 The BNP assay does not identify mild left ventricular diastolic dysfunction in asymptomatic diabetic patients

614 Prognostic role of B‐type natriuretic peptide in diabetic patients with acute decompensated heart failure

351 B‐type natriuretic peptide can predict the medium‐term risk of patients with acute heart failure and preserved systolic function

635 BNP‐guided treatment enables the timing of the patient's discharge and can predict the medium‐term risk in patients with acute heart failure

231 Rapid BNP test and doppler echocardiography provide a cost-effective screen for early diagnosis of heart failure

H014: Autonomic nervous system activity in borderline hypertension

L22 Target organ damage in subjects with white-coat and sustained hypertension: An insight from the harvest study